News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|August 22, 2017

Survey: What cancer terminologies do you prefer?

Author(s)Staff

Help us figure out the best, most respectful words to use when discussing cancer.

Advertisement

We'll be publishing another survey soon.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
CLL

Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit

ByJason M Broderick
December 7th 2025
follicular lymphoma

Epkinly Combo Effective in Second-Line R/R Follicular Lymphoma

ByGina Mauro
December 7th 2025
story about ponatinib and blinatumomab for ALL

A New Option Without Traditional Chemotherapy for Ph+ ALL

ByAriana Pelosci
December 7th 2025
AML

Azacitidine Plus Venclexta Superior to Chemo in Acute AML

ByJonah Feldman
December 7th 2025
DLBCL

Older Patients With DLBCL May Benefit From First-Line Epkinly Plus R-mini-CHOP

ByKristie L. Kahl
December 7th 2025
Advertisement
Advertisement

Trending on CURE

1

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

2

Every FDA Oncology Approval From November 2025

3

Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds

4

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

5

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.